IL97867A - Process for making indolones and intermediates used in it - Google Patents

Process for making indolones and intermediates used in it

Info

Publication number
IL97867A
IL97867A IL9786791A IL9786791A IL97867A IL 97867 A IL97867 A IL 97867A IL 9786791 A IL9786791 A IL 9786791A IL 9786791 A IL9786791 A IL 9786791A IL 97867 A IL97867 A IL 97867A
Authority
IL
Israel
Prior art keywords
preparation
water
equiv
compound
dihydro
Prior art date
Application number
IL9786791A
Other languages
English (en)
Hebrew (he)
Other versions
IL97867A0 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Priority to IL11102991A priority Critical patent/IL111029A/en
Priority to IL11102891A priority patent/IL111028A/en
Priority to IL11103091A priority patent/IL111030A/en
Publication of IL97867A0 publication Critical patent/IL97867A0/xx
Priority to IL11102994A priority patent/IL111029A0/xx
Priority to IL11102894A priority patent/IL111028A0/xx
Priority to IL11103094A priority patent/IL111030A0/xx
Publication of IL97867A publication Critical patent/IL97867A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78Benzoic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9786791A 1990-04-17 1991-04-16 Process for making indolones and intermediates used in it IL97867A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL11102991A IL111029A (en) 1990-04-17 1991-04-16 Esters of 4-hydroxyalkyl-indoline-2-helium
IL11102891A IL111028A (en) 1990-04-17 1991-04-16 4-Hydroxyalkyl- Indole-2-Onim
IL11103091A IL111030A (en) 1990-04-17 1991-04-16 Phenyl-alkyl alcohol esters are converted to position 2
IL11102994A IL111029A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11102894A IL111028A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11103094A IL111030A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process

Publications (2)

Publication Number Publication Date
IL97867A0 IL97867A0 (en) 1992-06-21
IL97867A true IL97867A (en) 1995-11-27

Family

ID=10674534

Family Applications (7)

Application Number Title Priority Date Filing Date
IL11103091A IL111030A (en) 1990-04-17 1991-04-16 Phenyl-alkyl alcohol esters are converted to position 2
IL11102991A IL111029A (en) 1990-04-17 1991-04-16 Esters of 4-hydroxyalkyl-indoline-2-helium
IL11102891A IL111028A (en) 1990-04-17 1991-04-16 4-Hydroxyalkyl- Indole-2-Onim
IL9786791A IL97867A (en) 1990-04-17 1991-04-16 Process for making indolones and intermediates used in it
IL11102894A IL111028A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11102994A IL111029A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11103094A IL111030A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones

Family Applications Before (3)

Application Number Title Priority Date Filing Date
IL11103091A IL111030A (en) 1990-04-17 1991-04-16 Phenyl-alkyl alcohol esters are converted to position 2
IL11102991A IL111029A (en) 1990-04-17 1991-04-16 Esters of 4-hydroxyalkyl-indoline-2-helium
IL11102891A IL111028A (en) 1990-04-17 1991-04-16 4-Hydroxyalkyl- Indole-2-Onim

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL11102894A IL111028A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11102994A IL111029A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11103094A IL111030A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones

Country Status (29)

Country Link
US (1) US5336781A (fr)
EP (1) EP0526529B1 (fr)
JP (2) JP2788548B2 (fr)
KR (1) KR0180215B1 (fr)
CN (1) CN1027892C (fr)
AP (1) AP184A (fr)
AT (1) ATE144251T1 (fr)
AU (2) AU640006B2 (fr)
CA (1) CA2080221C (fr)
CY (1) CY1981A (fr)
DE (1) DE69122753T2 (fr)
DK (1) DK0526529T3 (fr)
ES (1) ES2094812T3 (fr)
FI (1) FI101148B (fr)
GB (1) GB9008605D0 (fr)
GR (1) GR3022261T3 (fr)
HK (1) HK3097A (fr)
HU (1) HU214822B (fr)
IE (1) IE911262A1 (fr)
IL (7) IL111030A (fr)
MA (1) MA22133A1 (fr)
MY (1) MY109628A (fr)
NO (2) NO178396C (fr)
NZ (1) NZ237819A (fr)
PL (1) PL166736B1 (fr)
PT (1) PT97375B (fr)
SA (1) SA91110352B1 (fr)
WO (1) WO1991016306A1 (fr)
ZA (1) ZA912782B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
DE69131775T2 (de) * 1990-09-28 2000-04-20 Smithkline Beecham Corp. Verfahren zur Herstellung wasserlöslicher Camptothecinanaloge, sowie die Verbindungen 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (fr) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Nouvelles formes cristallines d'hydrochlorure de 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (fr) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Hydrochlorure de 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone sensiblement pur
WO2005080333A1 (fr) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Processus de purification de ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1,3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
KR0180215B1 (ko) 1999-03-20
NO178396C (no) 1996-03-20
WO1991016306A1 (fr) 1991-10-31
IL111030A (en) 1995-11-27
AU640006B2 (en) 1993-08-12
IL111029A (en) 1995-11-27
US5336781A (en) 1994-08-09
GR3022261T3 (en) 1997-04-30
FI924674A0 (fi) 1992-10-15
HUT64742A (en) 1994-02-28
PL166736B1 (pl) 1995-06-30
DK0526529T3 (da) 1996-11-18
NO1999012I1 (no) 1999-06-18
EP0526529A1 (fr) 1993-02-10
CY1981A (en) 1997-09-05
PT97375A (pt) 1992-01-31
HK3097A (en) 1997-01-10
IL111029A0 (en) 1994-11-28
EP0526529B1 (fr) 1996-10-16
ZA912782B (en) 1992-11-25
SA91110352B1 (ar) 2001-11-12
NO924028L (no) 1992-10-16
AU3566993A (en) 1993-06-03
ATE144251T1 (de) 1996-11-15
CA2080221A1 (fr) 1991-10-18
CN1056686A (zh) 1991-12-04
AP184A (en) 1992-06-30
CA2080221C (fr) 2000-11-14
AU646771B2 (en) 1994-03-03
JPH05506029A (ja) 1993-09-02
DE69122753T2 (de) 1997-05-07
PT97375B (pt) 1998-08-31
FI924674A (fi) 1992-10-15
HU9203261D0 (en) 1992-12-28
NO178396B (no) 1995-12-11
DE69122753D1 (de) 1996-11-21
HU214822B (hu) 1998-06-29
IL111028A (en) 1995-11-27
JP3044013B2 (ja) 2000-05-22
AU7656291A (en) 1991-11-11
AP9100251A0 (en) 1991-04-30
IL111028A0 (en) 1994-11-28
IL97867A0 (en) 1992-06-21
ES2094812T3 (es) 1997-02-01
JP2788548B2 (ja) 1998-08-20
IE911262A1 (en) 1991-10-23
MY109628A (en) 1997-03-31
FI101148B (fi) 1998-04-30
NZ237819A (en) 1993-05-26
JPH10251205A (ja) 1998-09-22
GB9008605D0 (en) 1990-06-13
IL111030A0 (en) 1994-11-28
MA22133A1 (fr) 1991-12-31
CN1027892C (zh) 1995-03-15
NO924028D0 (no) 1992-10-16

Similar Documents

Publication Publication Date Title
KR101461291B1 (ko) 약학적 활성 화합물의 제조 방법
AP184A (en) An improved process for the preparation of substituted indolone derivatives.
CZ283215B6 (cs) Způsob výroby 3-(alfa-methyxy)methylenbenzofuranonů
JP2721959B2 (ja) 1−(フェニル)−1−ヒドロキシー2−アミノー3−フルオロプロパン誘導体製造用中間体
JP2846042B2 (ja) インドールカルボン酸誘導体の製造法
Hurd et al. Hydroxamic acids and N-hydroxyimides related to pyridine, pyrazine, and quinoxaline
NO157637B (no) Gelformig anode og elektrokjemisk celle inneholdende denne
JP2622135B2 (ja) インデン誘導体及びその製造方法
NZ242374A (en) Phenyl alkyl ester compounds useful as intermediates in the preparation of 4-(aminoalkyl)-1,3-dihydro-2h-indol-2-one derivatives
IE59937B1 (en) Quinazolinediones and pyridopyrimidinediones
EP0238411A1 (fr) Dihydro-1,2 méthyl-4 oxo-1 5-H pyrido (4,3-b) indoles et leur procédé de synthèse
CZ282068B6 (cs) 3-Methoxy-4-[1-methyl-5-(2-methyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmethyl]-N-(2-methylfenylsulfonyl)benzamid, jeho farmaceuticky přijatelná sůl, způsob jejich přípravy a farmaceutické prostředky tyto látky obsahující
IE42956B1 (en) 4-amino-3-pyrrole carboxamides
US4543415A (en) Process for preparing tricyclic indoles
US4175086A (en) Cycloheptathiophene derivatives
NO123526B (fr)
JPH08239352A (ja) 6−ヒドロキシ−3−ピリジンカルボン酸エステルの製造に用いる中間体及びその製造方法
US4228295A (en) Novel cycloheptathiophene intermediates for the synthesis of biotin
IT202100020591A1 (it) Preparazione di un intermedio di un agente per il trattamento dell'anemia
IT202100020609A1 (it) Metodo di preparazione di agente adatto per il trattamento dell'anemia
Dagger et al. JD Hayler, SLB Howie, RG Giles*, A. Negus, PW Oxley, TC Walsgrove*, and SE Walsh
SK281056B6 (sk) Spôsob výroby 3-(alfa-metoxy)metylénbenzofuranónov
IL46953A (en) Triazolo-quinolines and their preparation
NO300688B1 (no) Fremgangsmåte for fremstilling av 1<beta>-ethyl-1<alfa>-(hydroxymethyl)-1,2,3,4,6,7,12,12b<alfa>octahydro-indolo£2,3-a|kinolizin og nye mellomprodukter
HU192648B (en) Process for producing octahydro-1,7a-/1-oxa-propano/-indolo/2,3-a/quinolizine derivatives and acid additional salts

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired